Search
for
Sort by
Research 61–90 of 1000+
- Cutaneous reactions to recombinant cytokine therapy
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Kava-induced acute cutaneous toxicity: An increasingly recognized characteristic clinicohistologic pattern
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- 9-cis-Retinoic Acid Capsules in the Treatment of AIDS-Related Kaposi Sarcoma
- Targeted therapy in melanoma
- Abnormal hair growth in patients (pts) with metastatic colorectal cancer (mCRC) treated with the anti-epidermal growth factor receptor (EGFr) monoclonal antibody (mAb) panitumumab (Pmab)
- Finasteride
- Pustular Eruption in a Patient Treated With Trametinib
- Supportive Oncodermatology: Addressing dermatologic adverse events associated with oncologic therapies
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- [Cutaneous effects in hormonal contraception].
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Management of the adverse effects of targeted therapy for cancer
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- Tufted hair folliculitis in a woman treated with trastuzumab
- Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- “PRIDE” Complex
- Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management.
- Acne inversa-like lesions associated with the multi-kinase inhibitor sorafenib
- Glycyrrhizic Acid Alleviates Osimertinib‐Induced Cutaneous Toxicity by Inhibiting Keratinocyte Apoptosis and Inflammation
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Novel Drugs Targeting Retinoic Acid Receptors
- Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology
- Post-oncologic skin health: cutaneous recovery and rehabilitation after cancer treatments
- Growth in skin surgery